Clinical Trial

Predictive Value of Albumin - Bilirubin Score and CRP - Albumin - Lymphocyte Index for HCC Prognosis After Radical Resection

Name: Predictive Value of Albumin - Bilirubin Score and CRP - Albumin - Lymphocyte Index for HCC Prognosis After Radical Resection — clinical trial record (NCT06934070)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

Evaluate the predictive value of the CALLY index and ALBI grading for the prognosis of patients with hepatocellular carcinoma (HCC) after radical resection, so as to provide a reference for clinical treatment.

Trial Details

NCT Number	NCT06934070
Lead Sponsor	Qiang Xu
Conditions	Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma (HCC) Prognosis
Enrollment	287 participants
Start Date	2025-04-03
Primary Completion	2025-04-03 (estimated)
Study Completion	2025-04-16 (estimated)
Updated on ClinicalTrials.gov	2025-04-18